Valenti, G.E.; Roveri, A.; Venerando, R.; Menichini, P.; Monti, P.; Tasso, B.; Traverso, N.; Domenicotti, C.; Marengo, B.
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants 2024, 13, 3.
https://doi.org/10.3390/antiox13010003
AMA Style
Valenti GE, Roveri A, Venerando R, Menichini P, Monti P, Tasso B, Traverso N, Domenicotti C, Marengo B.
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants. 2024; 13(1):3.
https://doi.org/10.3390/antiox13010003
Chicago/Turabian Style
Valenti, Giulia Elda, Antonella Roveri, Rina Venerando, Paola Menichini, Paola Monti, Bruno Tasso, Nicola Traverso, Cinzia Domenicotti, and Barbara Marengo.
2024. "PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis" Antioxidants 13, no. 1: 3.
https://doi.org/10.3390/antiox13010003
APA Style
Valenti, G. E., Roveri, A., Venerando, R., Menichini, P., Monti, P., Tasso, B., Traverso, N., Domenicotti, C., & Marengo, B.
(2024). PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis. Antioxidants, 13(1), 3.
https://doi.org/10.3390/antiox13010003